SE420977B - Forfarande for rening och isolering av hepatitvirus for vaccinframstellning - Google Patents

Forfarande for rening och isolering av hepatitvirus for vaccinframstellning

Info

Publication number
SE420977B
SE420977B SE7603386A SE7603386A SE420977B SE 420977 B SE420977 B SE 420977B SE 7603386 A SE7603386 A SE 7603386A SE 7603386 A SE7603386 A SE 7603386A SE 420977 B SE420977 B SE 420977B
Authority
SE
Sweden
Prior art keywords
hepatitvirus
insulating
cleaning
procedure
vaccine preparation
Prior art date
Application number
SE7603386A
Other languages
English (en)
Swedish (sv)
Other versions
SE7603386L (sv
Inventor
L-O Andersson
G M Einarsson
L P Kaplan
Original Assignee
Kabi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Ab filed Critical Kabi Ab
Priority to SE7603386A priority Critical patent/SE420977B/xx
Priority to CA271,971A priority patent/CA1073815A/fr
Priority to FR7707329A priority patent/FR2344629A1/fr
Priority to BE175747A priority patent/BE852416A/fr
Priority to JP2853377A priority patent/JPS52114018A/ja
Priority to US05/777,670 priority patent/US4138287A/en
Priority to NL7702784A priority patent/NL7702784A/xx
Priority to AU23313/77A priority patent/AU506385B2/en
Priority to GB11415/77A priority patent/GB1511997A/en
Priority to DE19772711773 priority patent/DE2711773A1/de
Publication of SE7603386L publication Critical patent/SE7603386L/xx
Publication of SE420977B publication Critical patent/SE420977B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7603386A 1976-03-18 1976-03-18 Forfarande for rening och isolering av hepatitvirus for vaccinframstellning SE420977B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE7603386A SE420977B (sv) 1976-03-18 1976-03-18 Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
CA271,971A CA1073815A (fr) 1976-03-18 1977-02-17 Methode d'isolation et de purification du virus de l'hepatite pour la preparation de vaccin
FR7707329A FR2344629A1 (fr) 1976-03-18 1977-03-11 Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
BE175747A BE852416A (fr) 1976-03-18 1977-03-14 Procede de purification et d'isolation du virus de l'hepatite en vue de l'utiliser dans la preparation de vaccins
JP2853377A JPS52114018A (en) 1976-03-18 1977-03-15 Purification and isolation of hepatisis virus for producing vaccine
US05/777,670 US4138287A (en) 1976-03-18 1977-03-15 Purifying and isolating method for hepatitis virus to use in preparing vaccine
NL7702784A NL7702784A (nl) 1976-03-18 1977-03-15 Werkwijze voor het zuiveren en isoleren van he- patitisvirus ten gebruike bij de bereiding van een vaccin.
AU23313/77A AU506385B2 (en) 1976-03-18 1977-03-16 Hepatitis b virus; isolation for vaccines
GB11415/77A GB1511997A (en) 1976-03-18 1977-03-17 Method for purification and isolation of hepatitis virus for use in the preparation of vaccine
DE19772711773 DE2711773A1 (de) 1976-03-18 1977-03-17 Verfahren zur reinigung und isolierung von hepatitisvirus zur herstellung eines impfstoffes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7603386A SE420977B (sv) 1976-03-18 1976-03-18 Forfarande for rening och isolering av hepatitvirus for vaccinframstellning

Publications (2)

Publication Number Publication Date
SE7603386L SE7603386L (sv) 1977-09-19
SE420977B true SE420977B (sv) 1981-11-16

Family

ID=20327330

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7603386A SE420977B (sv) 1976-03-18 1976-03-18 Forfarande for rening och isolering av hepatitvirus for vaccinframstellning

Country Status (10)

Country Link
US (1) US4138287A (fr)
JP (1) JPS52114018A (fr)
AU (1) AU506385B2 (fr)
BE (1) BE852416A (fr)
CA (1) CA1073815A (fr)
DE (1) DE2711773A1 (fr)
FR (1) FR2344629A1 (fr)
GB (1) GB1511997A (fr)
NL (1) NL7702784A (fr)
SE (1) SE420977B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4242324A (en) * 1979-04-04 1980-12-30 Merck & Co., Inc. Hepatitis B antigen
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US7767449B1 (en) * 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US4511473A (en) * 1982-02-09 1985-04-16 Amf Incorporated Fibrous media containing millimicron-sized particulates
JPS59164727A (ja) * 1983-03-09 1984-09-17 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
JPS59219239A (ja) * 1983-05-28 1984-12-10 Chemo Sero Therapeut Res Inst Ｂ型肝炎ウイルス表面抗原の精製方法
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen
CA1237998A (fr) * 1984-04-14 1988-06-14 Akihiro Ginnaga Methode de purification de l'hemagglutinine filamenteuse
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147185A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147187A (ja) * 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
JPS61103895A (ja) * 1984-10-26 1986-05-22 Green Cross Corp:The ＨＢｓＡｇの精製方法
SE503844C2 (sv) 1989-02-09 1996-09-16 Pharmacia Ab Förfarande för rening av streptokinaser
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
JP3615785B2 (ja) * 1994-04-28 2005-02-02 テルモ株式会社 Ｈｉｖ及びその関連物質除去材料
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
US6221855B1 (en) * 1999-03-11 2001-04-24 Wake Forest University Regulation of nucleic acid expression by heparan sulfate and biological equivalents thereof
JP4558652B2 (ja) * 2003-06-20 2010-10-06 マイクロビクス・バイオシステムズ・インコーポレイテツド ウイルス生産の改善
ES2932278T3 (es) * 2004-06-01 2023-01-17 Genzyme Corp Composiciones y métodos para prevenir la agregación del vector AAV
EP2066418A4 (fr) * 2006-09-29 2011-12-28 Ge Healthcare Bio Sciences Ab Matrice de séparation pour une purification virale
CN114210310B (zh) * 2021-12-06 2023-09-29 武汉瑞法医疗器械有限公司 乙型肝炎病毒和HBsAg免疫吸附材料的制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US3925152A (en) * 1971-06-18 1975-12-09 Exploaterings Ab Tbf Virus separation
US3896218A (en) * 1972-07-13 1975-07-22 Research Corp Radiommunoassay determining the hepatitis associated antigen content of blood
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
US3976767A (en) * 1975-04-14 1976-08-24 The New York Blood Center Purification of hepatitis B surface antigen by chromatography on agarose containing aminoalkyl residues
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration

Also Published As

Publication number Publication date
SE7603386L (sv) 1977-09-19
FR2344629B1 (fr) 1983-07-18
DE2711773A1 (de) 1977-09-22
GB1511997A (en) 1978-05-24
JPS52114018A (en) 1977-09-24
AU506385B2 (en) 1979-12-20
NL7702784A (nl) 1977-09-20
US4138287A (en) 1979-02-06
AU2331377A (en) 1978-09-21
CA1073815A (fr) 1980-03-18
BE852416A (fr) 1977-07-01
FR2344629A1 (fr) 1977-10-14

Similar Documents

Publication Publication Date Title
SE420977B (sv) Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
SE7904690L (sv) Cyanokarboxamidiner och kinazolin-forfarande
SE431073B (sv) Smidesforfarande och anordning for genomforande av forfarandet
FI790918A (fi) Vaermepump med flera kompressorer och med koordinerad avfrostning
SE7601277L (sv) Anordning och forfarande for kompensering av reaktiveffekt
FI792779A (fi) Foerfarande och anordning foer fyllning av saeckar med loesgod i en enligt deras vikt bestaemd maengd
FI791068A (fi) Oeverdragskomposition med denna komposition oeverdragna glasfibrer och anvaendning av dessa foer plastarmering
FI791229A (fi) Infaestningselement med foerankringsbult och exepansionskil
SE434946B (sv) Forfarande for framstellning av acylsackariner och acyl-3-oxo-1,2-densisotiazoliner
SE7802768L (sv) Forfarande och anordning for tillverkning av mattor
BE844284A (nl) Ethersulfaten bevattende reinigingsmiddelen en werkwijze ter bereiding daarvan
SE7709689L (sv) Forfarande och anordning for framstellning av alster av glas
FI793150A (fi) Foerfarande foer tvaerbindning av karboxymetylcellulosa och erhaollna produkter
SE7709333L (sv) Dihydro-oxo-nikotinsyror och forfarande for deras framstellning
BE859221A (fr) Bis-carbamoylsulfures n-substitues et leur preparation
SE7708486L (sv) Peptider och forfarande for deras framstellning
IT1122431B (it) Procedimento per scindere diidrossidifenil-alcani
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
SE7802024L (sv) Forfarande for framstellning av pyrrolokinoxalinoner och pyrrolobensodiazepinoner
SE7613947L (sv) Sekunder eteraminer och forfarande for deras framstellning
SE7900346L (sv) Beta- h- endorfinanaloger och forfarande for framstellning derav
SE7605069L (sv) 14beta-hydroxy 3-deoxikardenolider och forfarande for deras framstellning
BE850552A (fr) 2-furanones et leur preparation
SE7614386L (sv) Bensamider och forfarande for framstellning derav